{"id":"W2086142513","doi":"10.3816/clc.2001.n.018","title":"Phase I Study of the BLP25 (MUC1 Peptide) Liposomal Vaccine for Active Specific Immunotherapy in Stage IIIB/IV Non–Small-Cell Lung Cancer","year":2001,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":162,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Immunotherapy; Vaccination; Immunogenicity; Lung cancer; Cancer vaccine; Immunology; Immune system; Peptide vaccine; Internal medicine; MUC1; Cancer; Oncology; Gastroenterology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008893522,0.0004329848,0.001040134,0.0001511824,0.0002999332,0.00002294258,0.000841558,0.0004518249,0.001959963],"category_scores_gemma":[0.00009063089,0.0003183754,0.0004857585,0.0004485598,0.0002339494,0.0001427304,0.0001468219,0.0009190094,0.00001093737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002365385,"about_ca_system_score_gemma":0.0004550226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051811,"about_ca_topic_score_gemma":0.0009464,"domain_scores_codex":[0.9962337,0.000801963,0.001477327,0.0006894694,0.00009145979,0.0007060923],"domain_scores_gemma":[0.9969426,0.001199158,0.0006871945,0.0009298624,0.0002063569,0.00003487053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.08802296,0.01866898,0.3364715,0.0001860772,0.003445411,0.00002253021,0.008149855,0.0002382184,0.4466326,0.00004307395,0.01237942,0.08573935],"study_design_scores_gemma":[0.1553159,0.007955039,0.4834191,0.0007862917,0.0006404183,0.0000161251,0.004482305,0.0003099196,0.109884,0.00002635931,0.2357641,0.00140044],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9527614,0.04014684,0.00008709752,0.0004245512,0.002850218,0.003307719,0.000156122,0.00003777722,0.0002283052],"genre_scores_gemma":[0.9669158,0.01344023,0.00002318377,0.0005041074,0.0002305863,0.0008638757,0.00002038976,0.00008004037,0.01792178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3367486,"threshold_uncertainty_score":0.9999268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03284774457342199,"score_gpt":0.3810141725328872,"score_spread":0.3481664279594652,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}